Neither produces same-week visible results
"PubChem Compound Summary for CID 3623358, Emideltide;delta Sleep Inducing Peptide" PubChem, Graf MV, Kastin AJ
In our analysis of clinical studies, we found evidence that people using GLP-1 drugs do not experience higher overall cancer rates compared with non-users
25 Metabolic bariatric surgery has benefits beyond weight loss, with strong evidence that it reverses T2DM and significantly reduces the risk of major CVD outcomes, including coronary artery disease, myocardial infarction, cerebrovascular accident, heart failure, and CVD mortality
Supporting people with type 2 diabetes to lose weight and manage their blood sugar levels is key to reducing the risk of diabetes-related complications, and tirzepatide (Mounjaro) expands the range of treatment options available to help people achieve this. The MHRA said Mounjaro could be used to treat adults with type 2 diabetes and obese patients with a body mass index higher than 30